Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma

1 Aug 2015

Abstract excerpt

Infection with HIV ultimately leads to advanced immunodeficiency resulting in an increased incidence of cancer. For example primary effusion lymphoma (PEL) is an aggressive non-Hodgkin lymphoma with very poor prognosis that typically affects HIV infected individuals in advanced stages of immunodeficiency. Here we report on the dual anti-HIV and anti-PEL effect of targeting a single process common in both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma Diagnosis and Treatment
Share to Parvovirus B19 Infection Studies
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26501108
DOI: 10.1016/j.ebiom.2015.07.041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related LymphomaPMID 26501108Read ↗

The past, present, and future of CRM1/XPO1 inhibitorsSemantic proximity Read ↗

In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individualsSemantic proximity Read ↗

Multi-level systems analysis identifies XPO1 as a druggable target linked to NFκB activation, proliferation, tumor clonality and long-term survival in Adult T-cell LeukemiaSemantic proximity Read ↗

Targeting XPO1-Dependent Nuclear Export in Cancer.Semantic proximity Read ↗

The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

<scp>KPT</scp>‐330 inhibitor of <scp>CRM</scp>1 (<scp>XPO</scp>1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of <scp>T</scp>‐cell acute lymphoblastic leukaemia and acute myeloid leukaemiaSemantic proximity Read ↗

Inhibiting cancer cell hallmark features through nuclear export inhibitionSemantic proximity Read ↗

SINE (selective inhibitor of nuclear export) – translational science in a new class of anti-cancer agentsSemantic proximity Read ↗

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaSemantic proximity Read ↗

mRNA export and cancerSemantic proximity Read ↗

Small Molecule Inhibitors of CRM1Semantic proximity Read ↗

Simultaneous Targeting of XPO1 and BCL2 as an Effective Treatment Strategy for Double-Hit LymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.